Digital Development Partners, Inc. Stock Other OTC
Equities
DGDM
US25386D1028
Pharmaceuticals
Financials (USD)
Sales 2021 | 0.1 | Sales 2022 | 0.08 | Capitalization | 188K |
---|---|---|---|---|---|
Net income 2021 | -1M | Net income 2022 | -1M | EV / Sales 2021 | 59,667,541 x |
Net cash position 2021 | 436K | Net Debt 2022 | 749K | EV / Sales 2022 | 11,349,273 x |
P/E ratio 2021 |
-2.42
x | P/E ratio 2022 |
-0.15
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 55.12% |
1st Jan change | Capi. | |
---|---|---|
+37.37% | 6.02B | |
-15.69% | 4.49B | |
-12.46% | 3.06B | |
-0.12% | 3.04B | |
+0.47% | 2.61B | |
+36.06% | 1.81B | |
+0.84% | 1.66B | |
-10.60% | 1.63B | |
-12.03% | 1.55B |